Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatiana Lawrence

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Blood Reviews|March 30, 2021
Clinical overview and practical considerations for optimizing romiplostim therapy in patients with immune thrombocytopeniaDavid J Kuter, Michael D Tarantino, Tatiana Lawrence
Leukemia & Lymphoma|May 17, 2017
Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemiaCarolyn Owen, Anna Christofides, Nathalie Johnson, et al.
Therapeutic Advances in Medical Oncology|January 10, 2022
Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the USRan Jin, Reshma L Mahtani, Neil Accortt, et al.
Drug Design, Development and Therapy|June 3, 2021
A Review of Romiplostim Mechanism of Action and Clinical ApplicabilityJames B Bussel, Gerald Soff, Adriana Balduzzi, et al.
BMC Cancer|May 28, 2021
Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safetyReshma Mahtani, Jeffrey Crawford, Sinéad M Flannery, et al.
JAMA Oncology|August 10, 2023
Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical TrialReinhard Dummer, David E Gyorki, John R Hyngstrom, et al.
American Journal of Hematology|September 26, 2022
Romiplostim use in pregnant women with immune thrombocytopeniaJames B Bussel, Nichola Cooper, Tatiana Lawrence, et al.
Blood Advances|October 12, 2021
Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registryCharles Bowers, Daniel T Mytych, Tatiana Lawrence, et al.
Current Opinion in Hematology|December 18, 2004
Autosomal-dominant primary immunodeficienciesTatiana Lawrence, Anne Puel, Janine Reichenbach, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practiceAhuva Averin, Amanda Silvia, Lois Lamerato, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Blood Reviews|March 30, 2021
Clinical overview and practical considerations for optimizing romiplostim therapy in patients with immune thrombocytopeniaDavid J Kuter, Michael D Tarantino, Tatiana Lawrence
Leukemia & Lymphoma|May 17, 2017
Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemiaCarolyn Owen, Anna Christofides, Nathalie Johnson, et al.
Therapeutic Advances in Medical Oncology|January 10, 2022
Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the USRan Jin, Reshma L Mahtani, Neil Accortt, et al.
Drug Design, Development and Therapy|June 3, 2021
A Review of Romiplostim Mechanism of Action and Clinical ApplicabilityJames B Bussel, Gerald Soff, Adriana Balduzzi, et al.
BMC Cancer|May 28, 2021
Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safetyReshma Mahtani, Jeffrey Crawford, Sinéad M Flannery, et al.
JAMA Oncology|August 10, 2023
Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical TrialReinhard Dummer, David E Gyorki, John R Hyngstrom, et al.
American Journal of Hematology|September 26, 2022
Romiplostim use in pregnant women with immune thrombocytopeniaJames B Bussel, Nichola Cooper, Tatiana Lawrence, et al.
Blood Advances|October 12, 2021
Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registryCharles Bowers, Daniel T Mytych, Tatiana Lawrence, et al.
Current Opinion in Hematology|December 18, 2004
Autosomal-dominant primary immunodeficienciesTatiana Lawrence, Anne Puel, Janine Reichenbach, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practiceAhuva Averin, Amanda Silvia, Lois Lamerato, et al.
Pageof 2